HRP20041065A2 - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors Download PDF

Info

Publication number
HRP20041065A2
HRP20041065A2 HR20041065A HRP20041065A HRP20041065A2 HR P20041065 A2 HRP20041065 A2 HR P20041065A2 HR 20041065 A HR20041065 A HR 20041065A HR P20041065 A HRP20041065 A HR P20041065A HR P20041065 A2 HRP20041065 A2 HR P20041065A2
Authority
HR
Croatia
Prior art keywords
alkyl
cooh
optionally substituted
image
mmol
Prior art date
Application number
HR20041065A
Other languages
English (en)
Croatian (hr)
Inventor
Yoakim Christiane
Thavonekham Bounkham
Simoneau Bruno
Naud Julie
O'meara Jeffrey
Malenfant Eric
R. Landry Serge
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HRP20041065A2 publication Critical patent/HRP20041065A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20041065A 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors HRP20041065A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
HRP20041065A2 true HRP20041065A2 (en) 2005-04-30

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20041065A HRP20041065A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Country Status (28)

Country Link
US (1) US6806265B2 (es)
EP (1) EP1506195B1 (es)
JP (1) JP4230448B2 (es)
KR (1) KR20050008716A (es)
CN (1) CN1318421C (es)
AR (1) AR040027A1 (es)
AT (1) ATE412653T1 (es)
AU (1) AU2003229186A1 (es)
BR (1) BR0310033A (es)
CA (1) CA2485916C (es)
DE (1) DE60324418D1 (es)
EA (1) EA009178B1 (es)
EC (1) ECSP045432A (es)
ES (1) ES2315492T3 (es)
HR (1) HRP20041065A2 (es)
IL (1) IL163753A0 (es)
MX (1) MXPA04010409A (es)
MY (1) MY134646A (es)
NO (1) NO20044104L (es)
NZ (1) NZ536736A (es)
PE (1) PE20040365A1 (es)
PL (1) PL371663A1 (es)
RS (1) RS98004A (es)
TW (1) TW200404071A (es)
UA (1) UA79285C2 (es)
UY (1) UY27809A1 (es)
WO (1) WO2003097644A2 (es)
ZA (1) ZA200406912B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
EP1610797A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
KR101415503B1 (ko) * 2003-07-17 2014-07-04 플렉시콘, 인코퍼레이티드 Ppar 활성 화합물
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
US7531568B2 (en) * 2004-11-30 2009-05-12 Plexxikon, Inc. PPAR active compounds
AU2006287528A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds
AU2006287513A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1, 3-disubstituted indole derivatives for use as PPAR modulators
EP1940767A2 (en) * 2005-09-07 2008-07-09 Plexxikon, Inc. Pparactive compounds
US8492428B2 (en) 2005-09-20 2013-07-23 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
JP2017535573A (ja) 2014-11-25 2017-11-30 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピリドベンゾジアゼピノン誘導体およびそれの使用
CN110446708B (zh) 2017-07-21 2022-12-02 安塔比奥公司 化学化合物
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
JP2024534799A (ja) * 2021-08-20 2024-09-26 エナンタ ファーマシューティカルズ インコーポレイテッド 17-ベータ-ヒドロキシステロイドデヒドロゲナーゼ13型阻害剤及びその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
ATE412653T1 (de) 2008-11-15
PE20040365A1 (es) 2004-07-22
ES2315492T3 (es) 2009-04-01
IL163753A0 (en) 2005-12-18
KR20050008716A (ko) 2005-01-21
US20040006071A1 (en) 2004-01-08
PL371663A1 (en) 2005-06-27
CA2485916A1 (en) 2003-11-27
MXPA04010409A (es) 2005-02-17
BR0310033A (pt) 2005-02-15
HK1080849A1 (en) 2006-05-04
WO2003097644A3 (en) 2004-02-05
WO2003097644A2 (en) 2003-11-27
EP1506195A2 (en) 2005-02-16
UA79285C2 (en) 2007-06-11
RS98004A (sr) 2006-12-15
CN1653066A (zh) 2005-08-10
AU2003229186A1 (en) 2003-12-02
EA200401482A1 (ru) 2005-06-30
US6806265B2 (en) 2004-10-19
AR040027A1 (es) 2005-03-09
EA009178B1 (ru) 2007-12-28
NZ536736A (en) 2006-11-30
MY134646A (en) 2007-12-31
CA2485916C (en) 2009-12-08
JP2005526851A (ja) 2005-09-08
TW200404071A (en) 2004-03-16
CN1318421C (zh) 2007-05-30
DE60324418D1 (de) 2008-12-11
ZA200406912B (en) 2006-06-28
UY27809A1 (es) 2003-12-31
NO20044104L (no) 2004-12-01
ECSP045432A (es) 2005-01-03
JP4230448B2 (ja) 2009-02-25
EP1506195B1 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
CA2485916C (en) Non-nucleoside reverse transcriptase inhibitors
US7273861B2 (en) Non-nucleoside reverse transcriptase inhibitors
EP1554276B1 (en) Non-nucleoside reverse transcriptase inhibitors
CA2450868C (en) Non-nucleoside reverse transcriptase inhibitors
AU2001270370A1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1373267B1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1305313A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors
KR20250017244A (ko) 플라비바이러스 저해제
HK1080849B (en) Non-nucleoside reverse transcriptase inhibitors
CA2479216C (en) Dipyridodiazepinones as reverse transcriptase inhibitors

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070503

Year of fee payment: 5

OBST Application withdrawn